OPPapers.com Essay Index >> Business >> Ms.
We have many free term papers and essays on Ms.. We also have a wide variety of research papers and book reports available to you for free. You can browse our collection of term papers or use our search engine.
MS Almost Too Old With all of the medical and technological advances in today?s society, one may be prompted to ask why there are so many unanswered questions about
Making Utilities For Ms-dos Making Utilities for MS-DOS Michael Sokolov English 4 Mr. Siedlecki February 1, 1996 Making Utilities for MS-DOS These days, when computers
MS Windows versus Linux Introduction Many of today's computer users, operators, programmers and hackers are faced with numerous challenges to maintain an efficient
MS Multiple Sclerosis 6560 Fannin, Suite 1224 Houston, TX 77030 (713) 798-7707 infor@mnss.org Mission: The mission of the National Multiple Sclerosis Society is
GC/MS Purpose: The Purpose of this experiment is to determine the quantity of caffeine in a sample using an instrument called Gas Chromatography-Mass Spectroscopy
Submitted by lynnc1977 on July 8, 2007
Category: Business
Words: 1248 | Pages: 5
Views: 171
Popularity Rank: 82,321
Average Member Grade: N/A (Add a Comment / Grade this Paper)
Riordan Manufacturing Bio:
Riordan Manufacturing (Riordan) is an international plastics manufacturer. Riordan was founded by Dr. Michael Riordan, a professor of chemistry, in 1992. Riordan's Headquarters is in San Jose, California. The company currently has two domestic manufacturing plants, one in Albany, Georgia, and one in Pontiac, Michigan. In the spring of 2000 Riordan opened its first international manufacturing plant in Hangzhou, China. Riordan employs 550 people across the globe with projected earnings of $46 million dollars.
Riordan's diverse product line includes the manufacturing of plastic bottles, fans, heart valves, medical stents, and custom plastic parts. Riordan's existing clients are automotive parts manufacturers, aircraft manufacturers, the Department of Defense, beverage makers and bottlers, and medical distributors.
Cause For Litigation:
An international bioethics related legal issue has arisen out of Riordan's recent development of a genetically engineered heart valve. This heart valve is a revolutionary hybrid design consisting of a newly developed substrate called bio-plastics. Bio-plastics are created using human stem cells that are infused with a plastics-based gel that provides a semi-rigid structural framework which supports the living tissue.
This newly patented process of creating bio-plastic heart valves has yet to receive the required Food and Drug Administrations (FDA) clearance in the United States. Riordan has a long history of being an aggressive company who takes calculated risks to bring new products to market. These two factors have contributed to Riordan's decision to release this new product in China, which does not require the rigorous testing and scrutiny of the FDA.
Everything seemed to be going well until Jimmy Dupont, a Riordan Geneticist, was summarily fired after the company's internal security chief compiled a comprehensive dossier which Riordan claims is...
You must Login to view the entire paper.
If you are not a member yet, Sign Up for free!